Market Closed -
NSE India S.E.
07:43:46 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
108.5
INR
|
+0.88%
|
|
+3.19%
|
-2.65%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
11,073
|
9,303
|
4,799
|
7,884
|
20,723
|
14,706
|
Enterprise Value (EV)
1 |
12,993
|
10,795
|
5,741
|
7,572
|
19,680
|
13,082
|
P/E ratio
|
9.5
x
|
4.88
x
|
2.36
x
|
5.84
x
|
8.56
x
|
7.91
x
|
Yield
|
2.45%
|
2.91%
|
11.3%
|
3.44%
|
1.31%
|
1.84%
|
Capitalization / Revenue
|
0.85
x
|
0.68
x
|
0.32
x
|
0.52
x
|
1.06
x
|
0.62
x
|
EV / Revenue
|
0.99
x
|
0.78
x
|
0.39
x
|
0.5
x
|
1
x
|
0.55
x
|
EV / EBITDA
|
6.14
x
|
3.53
x
|
2.05
x
|
3.45
x
|
7.41
x
|
4.34
x
|
EV / FCF
|
238
x
|
45.1
x
|
6.36
x
|
8.85
x
|
43.9
x
|
19.3
x
|
FCF Yield
|
0.42%
|
2.22%
|
15.7%
|
11.3%
|
2.28%
|
5.17%
|
Price to Book
|
1.12
x
|
0.82
x
|
0.42
x
|
0.61
x
|
1.36
x
|
0.95
x
|
Nbr of stocks (in thousands)
|
135,535
|
135,535
|
135,535
|
135,535
|
135,535
|
135,535
|
Reference price
2 |
81.70
|
68.64
|
35.41
|
58.17
|
152.9
|
108.5
|
Announcement Date
|
5/30/18
|
9/4/19
|
6/27/20
|
9/1/21
|
9/3/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
13,076
|
13,764
|
14,775
|
15,091
|
19,616
|
23,676
|
EBITDA
1 |
2,117
|
3,060
|
2,806
|
2,192
|
2,655
|
3,017
|
EBIT
1 |
1,566
|
2,505
|
2,182
|
1,584
|
2,019
|
2,350
|
Operating Margin
|
11.97%
|
18.2%
|
14.77%
|
10.49%
|
10.29%
|
9.93%
|
Earnings before Tax (EBT)
1 |
1,678
|
2,784
|
2,309
|
1,702
|
2,998
|
2,531
|
Net income
1 |
1,165
|
1,905
|
2,031
|
1,350
|
2,422
|
1,860
|
Net margin
|
8.91%
|
13.84%
|
13.75%
|
8.94%
|
12.35%
|
7.85%
|
EPS
2 |
8.598
|
14.05
|
14.98
|
9.958
|
17.87
|
13.72
|
Free Cash Flow
1 |
54.52
|
239.3
|
903
|
855.6
|
448.6
|
676.2
|
FCF margin
|
0.42%
|
1.74%
|
6.11%
|
5.67%
|
2.29%
|
2.86%
|
FCF Conversion (EBITDA)
|
2.57%
|
7.82%
|
32.17%
|
39.03%
|
16.9%
|
22.41%
|
FCF Conversion (Net income)
|
4.68%
|
12.56%
|
44.46%
|
63.39%
|
18.52%
|
36.36%
|
Dividend per Share
2 |
2.000
|
2.000
|
4.000
|
2.000
|
2.000
|
2.000
|
Announcement Date
|
5/30/18
|
9/4/19
|
6/27/20
|
9/1/21
|
9/3/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,920
|
1,492
|
942
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
312
|
1,043
|
1,623
|
Leverage (Debt/EBITDA)
|
0.9068
x
|
0.4875
x
|
0.3357
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
54.5
|
239
|
903
|
856
|
449
|
676
|
ROE (net income / shareholders' equity)
|
11.4%
|
16.9%
|
17.2%
|
10.8%
|
16.4%
|
11.7%
|
ROA (Net income/ Total Assets)
|
5.84%
|
8.97%
|
7.44%
|
5.37%
|
6.44%
|
7.21%
|
Assets
1 |
19,942
|
21,240
|
27,298
|
25,136
|
37,606
|
25,786
|
Book Value Per Share
2 |
72.90
|
83.40
|
85.10
|
95.70
|
112.0
|
114.0
|
Cash Flow per Share
2 |
2.600
|
2.870
|
4.320
|
1.520
|
2.500
|
4.210
|
Capex
1 |
1,114
|
652
|
515
|
902
|
931
|
2,168
|
Capex / Sales
|
8.52%
|
4.73%
|
3.49%
|
5.98%
|
4.75%
|
9.16%
|
Announcement Date
|
5/30/18
|
9/4/19
|
6/27/20
|
9/1/21
|
9/3/22
|
9/1/23
|
|
1st Jan change
|
Capi.
|
---|
| -2.65% | 176M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|